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When pouring water on the
fire makes it burn brighter
Earlier work seems to suggest that overexpression of uncoupling protein 1 would be anti-inflammatory. However, new
findings show that expression of uncoupling protein 1 in aortic smooth muscle cells of mice increases reactive oxygen
species, activates the renin-angiotensin system, elevates blood pressure, and worsens atherosclerosis.Uncoupling proteins are inner mitochon- t
drial membrane anion transporters that p
callow protons to leak back into the mito-
chondrial matrix and decrease the en- p
iergy available for ADP phosphorylation.
Less ADP phosphorylation should lead T
ito the production of less reactive oxygen
species (ROS). Thus, Semenkovich and i
acolleagues (Bernal-Mizrachi et al., 2005)
expected that the overexpression of un-
fcoupling protein 1 (UCP1) in mice would
lead to decreased ROS. Surprisingly, u
athey found that doxycycline-inducible
expression of UCP1, restricted to vascu- t
Wlar smooth muscle cells by use of the
SM22α promoter, resulted in markedly R
bincreased levels of aortic superoxide and
nitrotyrosine. Transgenic expression of i
iUCP1 increased peroxynitrite produc-
tion due to the interaction of superoxide t
twith nitric oxide in the aorta. As a result,
blood pressure (as measured by nonin- a
evasive tail cuff as well as with implanted
telemetry units) was significantly in- i
Acreased. The authors also found that
atherosclerosis, measured by en face t
lanalysis, was increased on feeding a
high-cholesterol high-fat diet (Western t
tdiet) to transgene-bearing mice that
were crossbred to also lack apolipopro- m
(tein (apo) E. When these mice were fed a
chow diet, blood pressure but not aortic m
tatherosclerosis was increased; the au-6hors concluded that increased blood
1ressure was not the cause of the in-
reased atherosclerosis. Plasma lipo- b
arotein profiles were also not increased
n the mice expressing vascular UCP1. l
lhe mice did show a significant increase
n plasma renin activity and a decrease s
wn urinary sodium excretion, confirming
ctivation of the renin-angiotensin system. i
lWhile the increase in ROS resulting
rom the overexpression of UCP1 was t
lnexpected, the subsequent increase in
therosclerosis after crossbreeding the f
aransgene into apoE null mice fed a
estern diet was not. The coupling of a
dOS and lipids in the artery wall has
een shown to increase atherosclerosis i
an a number of mouse models. The bind-
ng of lipoproteins containing apoB in c
che artery wall is common in all species
hat develop atherosclerosis. ApoB has a
dn amino acid sequence that binds to
xtracellular matrix proteoglycans found s
fn the subendothelial space of arteries.
s a result, the concentration of lipopro- n
aeins containing apoB (e.g., low-density
ipoproteins [LDL]) in artery walls is twice t
that in the circulation, even in normal ar-
eries. This is in contrast to apoA-I, the t
sajor protein in high-density lipoproteins
HDL). The concentration of apoA-I in nor- o
Ral arteries is far less than the concen-
ration in the circulation. aPioneering studies, done more than
00 years ago, demonstrated that rab-
its fed a high-cholesterol diet develop
therosclerosis; subsequent epidemio-
ogic studies have correlated LDL cho-
esterol levels with risk for atherosclero-
is. Because of these findings, early
ork focused on the role of cholesterol
n the apoB-containing lipoproteins. These
ipoproteins are not only rich in choles-
erol but are also very rich in phospho-
ipids, which contain polyunsaturated
atty acids, particularly arachidonic acid
nd linoleic acid. These phospholipids
re highly susceptible to free radical oxi-
ation. As shown in Figure 1, the result-
ng oxidized phospholipids induce the
rtery wall cells to produce potent mono-
yte chemoattractants such as mono-
yte chemoattractant-1 (MCP-1) and
lso cause the artery wall cells to pro-
uce monocyte differentiation factors
uch as monocyte colony stimulating
actor (M-CSF) (Navab et al., 2004). A
umber of different ROS can attack ar-
chidonic and linoleic acids, resulting in
he formation of the same proinflamma-
ory oxidized phospholipids. Once formed,
hese proinflammatory lipids evoke the
ame inflammatory response, regardless
f the specific ROS that produced them.
OS derived from a variety of cell types
nd pathways in the artery wall haveCELL METABOLISM : JULY 2005

























Figure 1. Oxidized phospholipids induce artery wall inflammation
Lipoproteins (LP) containing apoB (apoB-LP) are trapped in the subendothelial space of arteries because they
bind to the extracellular matrix proteins (ECM). Reactive oxygen species (ROS) derived from multiple pathways d
in the artery wall (e.g., conditional overexpression of uncoupling protein 1, NADPH oxidase pathway, 12/15- wlipoxygenase pathway, 5-lipoxygenase pathway, myeloperoxidase pathway) oxidize apoB-LP phospholipids,
dwhich contain arachidonic acid or linoleic acid and generate pro-inflammatory oxidized phospholipids. These
oxidized phospholipids stimulate the production of monocyte chemoattactants such as MCP-1 and monocyte S
differentiation factors such as M-CSF. This causes the monocytes to migrate into the artery wall and differenti- m
ate into macrophages. The renin-angiotensin system enhances the production of ROS and provides a positive s
feedback loop to amplify the inflammation.
f
t
abeen shown to increase atherosclerosis b
in mouse models and/or have been found F
associated with human atherosclerotic r
lesions. ROS derived from the NADPH e
oxidase pathway (Cathcart 2004), the U
12/15-lipoxygenase pathway (Huo et al., u
2004), the 5-lipoxygenase pathway (Meh- i
rabian et al., 2002), and the myeloper- t
oxidase pathway (Nicholls and Hazen, t
s2005) have all been shown to increase
atherosclerosis in mouse models and/or s
thave been found associated with human
atherosclerotic lesions. The oxidized phos- c
wpholipids resulting from free radical oxi-
dation evoke an inflammatory reaction in a
the artery wall similar to that seen in tis- e
sues infected with Mycobacteria (Navab r
et al., 2004). This inflammatory reaction, h
which is rich in monocyte macrophages a
and poor in neutrophils, was seen in the
UCP1-overexpressing apoE null mice i
i(Bernal-Mizrachi et al., 2005).
The activity of some of the ROS-gen- e
erating and oxidized phospholipid-pro- e
ducing pathways is significantly increased oCELL METABOLISM : JULY 2005iy the renin-angiotensin pathway (see
iigure 1 and Brasier et al. [2002]). The
(enin-angiotensin pathway was also mark-
idly upregulated by the overexpression of
dCP1 (see above). Angiotensin II, a prod-
lct of the renin-angiotensin pathway, can
ancrease the production of ROS, inflamma-
aory cytokines, and adhesion molecules in
mhe artery wall. Additionally, the aortic
mooth muscle cell hypertrophy that re-
Aults from angiotensin II-induced hyper-
ension requires the recruitment of mono- A
yte-macrophages (Bush et al., 2000),
hich was the major cell type in the A
therosclerotic lesions described by Sem- D
nkovich and colleagues (Bernal-Miz- D
achi et al., 2005). This further links ROS,
ypertension, and inflammation with L
therosclerosis.
Currently, the major focus for prevent-
Sng and treating atherosclerosis is reduc-
ng plasma LDL cholesterol levels. Sem-
Bnkovich and colleagues (Bernal-Mizrachi m
t al., 2005) noted that the changes they T
kbserved were independent of changesn plasma lipoprotein profiles, and the
uthors suggested that therapies inde-
endent of lipid lowering might be effec-
ive in the prevention and treatment of
therosclerosis. It is interesting to note
hat, in apoE null mice, oral treatment
ith an apoA-I mimetic peptide (D-4F)
esulted in dramatic reductions in ath-
rosclerosis that were independent of
hanges in plasma lipids but were asso-
iated with decreased ROS (Navab et
l., 2005a). This effect was synergistic
ith the non-lipid-lowering actions of
tatins (Navab et al., 2005b). These re-
ults lend support to Semenkovich and
olleagues’ (Bernal-Mizrachi et al., 2005)
uggestion that treatments directed at
educing ROS independent of lipid low-
ring may be beneficial in the prevention
nd treatment of atherosclerosis.
The recent studies by Semenkovich
nd colleagues (Bernal-Mizrachi et al.,
005) originated with the serendipitous
inding that overexpressing UCP1 in
mooth muscle cells unexpectedly in-
reased ROS instead of causing the pre-
icted decrease. The mechanisms by
hich ROS were increased, rather than
ecreased, remain to be determined.
tudies directed at discovering these
echanisms are likely to reveal new in-
ights into mitochondrial structure and
unction. Regardless of the mechanisms,
he potential importance of mitochondria
s a source of ROS that can participate
n both hypertension and atherosclerosis
s clearly highlighted by these studies
Bernal-Mizrachi et al., 2005). It will be
nteresting and potentially important to
etermine if the benefits of the non-
ipid-lowering properties of statins and
poA-I mimetic peptides such as D-4F
re in part mediated by an action on
itochondrial ROS.
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